---
title: "Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans | IBO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281655272.md"
description: "Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans | IBO Stock News"
datetime: "2026-04-03T09:55:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281655272.md)
  - [en](https://longbridge.com/en/news/281655272.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281655272.md)
---

# Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans | IBO Stock News

Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans | IBO Stock News

### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBO.US](https://longbridge.com/en/quote/IBO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Insider Move at Impact BioMedical, Inc. Sparks Fresh Wave of Investor Buzz](https://longbridge.com/en/news/280567252.md)
- [Impact Biomedical Q2 FY26 net loss narrows 95% to $700,000](https://longbridge.com/en/news/295275544.md)
- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md)
- [Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026 | PSNL Stock News](https://longbridge.com/en/news/283480044.md)